Gossamer Bio GOSS
NASDAQ GOSS
$9.60 +0.14 (+1.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Gains from Investment Securities (2019 - 2026)

Updated

Analysis

Gossamer Bio (GOSS) Gains from Investment Securities (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Gossamer Bio 38.40 Mn -435.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.11 Mn
Sep 30, 2020 3,000.00
Jun 30, 2020 214,000.00
Mar 31, 2020 39,000.00
Dec 31, 2019 27,000.00
API Access

Gossamer Bio Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=GOSS&period=max&api_key=YOUR_API_KEY